• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产前倍他米松试验参与者早产50年后的健康结局

Health Outcomes 50 Years After Preterm Birth in Participants of a Trial of Antenatal Betamethasone.

作者信息

Walters Anthony G B, Gamble Greg D, Crowther Caroline A, Dalziel Stuart R, Eagleton Carl L, McKinlay Christopher J D, Milne Barry J, Harding Jane E

机构信息

Liggins Institute, Auckland, New Zealand.

Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland, New Zealand.

出版信息

Pediatrics. 2025 Jan 1;155(1). doi: 10.1542/peds.2024-066929.

DOI:10.1542/peds.2024-066929
PMID:39679590
Abstract

BACKGROUND AND OBJECTIVES

Preterm birth results in neonatal and childhood morbidity and mortality. Additionally, population-based studies show poorer cardiovascular health in adult survivors, but a full range of health outcomes has not been investigated into midlife. We aimed to assess the health outcomes after preterm vs term birth at 50 years in survivors of a randomized trial of antenatal betamethasone.

METHODS

Participants were asked to complete a health questionnaire and for consent to access administrative data. Participants deceased prior to follow-up were assessed with administrative data alone. The primary outcome was a composite: any of diabetes mellitus, prediabetes, treated hypertension, treated dyslipidemia, or a previous major adverse cardiovascular event. Secondary outcomes included respiratory, mental health, educational, and other health outcomes.

RESULTS

We included 470 participants: 424 assessed at mean age 49.3 years and 46 who died after infancy. The primary outcome occurred in 34.5% (112/325) of those born preterm and 29.9% (43/144) of those born at term; adjusted relative risk (aRR) 1.14 (95% CI, 0.85-1.54; P = .37). Cardiovascular events were less common in those born preterm (9/326 [2.8%] vs 10/144 [6.9%]; aRR 0.33, 95% CI, 0.14-0.79), while self-reported hypertension was more common (101/291 [34.7%] vs 23/116 [19.8%]; aRR 1.74, 95% CI, 1.16-2.61), although treated hypertension was not statistically significantly different (66/323 [20.4%] vs 22/143 [15.4%]; aRR 1.32, 95% CI, 0.84-2.06). Other components of the composite endpoint were similar between those born preterm and at term.

CONCLUSIONS

Those aged 50 years born preterm were more likely to have hypertension but had similar risk of diabetes, prediabetes, and dyslipidemia than those born at term, and their risk of cardiovascular events was lower.

摘要

背景与目的

早产会导致新生儿及儿童期发病和死亡。此外,基于人群的研究表明,成年幸存者的心血管健康状况较差,但尚未对中年时期的一系列健康结局进行调查。我们旨在评估产前倍他米松随机试验的幸存者在50岁时早产与足月出生后的健康结局。

方法

要求参与者完成一份健康问卷并同意获取行政数据。在随访前死亡的参与者仅通过行政数据进行评估。主要结局是一个复合指标:糖尿病、糖尿病前期、治疗的高血压、治疗的血脂异常或既往重大心血管事件中的任何一项。次要结局包括呼吸、心理健康、教育及其他健康结局。

结果

我们纳入了470名参与者:424名在平均年龄49.3岁时接受评估,46名在婴儿期后死亡。主要结局在早产出生者中发生率为34.5%(112/325),足月出生者中为29.9%(43/144);调整后相对风险(aRR)为1.14(95%CI,0.85 - 1.54;P = 0.37)。心血管事件在早产出生者中较少见(9/326 [2.8%] 对比10/144 [6.9%];aRR 0.33,95%CI,0.14 - 0.79),而自我报告的高血压更常见(101/291 [34.7%] 对比23/116 [19.8%];aRR 1.74,95%CI,1.16 - 2.61),尽管治疗的高血压在统计学上无显著差异(66/323 [20.4%] 对比22/143 [15.4%];aRR 1.32,95%CI,0.84 - 2.06)。复合终点的其他组成部分在早产和足月出生者之间相似。

结论

50岁的早产出生者患高血压的可能性更大,但与足月出生者相比,患糖尿病、糖尿病前期和血脂异常的风险相似,且其心血管事件风险较低。

相似文献

1
Health Outcomes 50 Years After Preterm Birth in Participants of a Trial of Antenatal Betamethasone.产前倍他米松试验参与者早产50年后的健康结局
Pediatrics. 2025 Jan 1;155(1). doi: 10.1542/peds.2024-066929.
2
Cardiovascular outcomes 50 years after antenatal exposure to betamethasone: Follow-up of a randomised double-blind, placebo-controlled trial.产前暴露于倍他米松50年后的心血管结局:一项随机双盲、安慰剂对照试验的随访
PLoS Med. 2024 Apr 1;21(4):e1004378. doi: 10.1371/journal.pmed.1004378. eCollection 2024 Apr.
3
Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids: The ALPS Follow-Up Study.晚期早产儿产前皮质类固醇治疗后的神经发育结局:ALPS 随访研究。
JAMA. 2024 May 21;331(19):1629-1637. doi: 10.1001/jama.2024.4303.
4
Cost-effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial.产前皮质类固醇治疗与无治疗在有晚期早产风险的妇女中的成本效益:一项随机临床试验的二次分析。
JAMA Pediatr. 2019 May 1;173(5):462-468. doi: 10.1001/jamapediatrics.2019.0032.
5
Short Duration of Antenatal Corticosteroid Exposure and Outcomes in Extremely Preterm Infants.极早产儿产前皮质类固醇暴露的短持续时间与结局
JAMA Netw Open. 2025 Feb 3;8(2):e2461312. doi: 10.1001/jamanetworkopen.2024.61312.
6
Association of Fetal Growth Restriction With Neurocognitive Function After Repeated Antenatal Betamethasone Treatment vs Placebo: Secondary Analysis of the ACTORDS Randomized Clinical Trial.胎儿生长受限与重复产前倍他米松治疗与安慰剂治疗后神经认知功能的关系:ACTORDS 随机临床试验的二次分析。
JAMA Netw Open. 2019 Feb 1;2(2):e187636. doi: 10.1001/jamanetworkopen.2018.7636.
7
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.不同的皮质类固醇药物和方案用于加速有早产风险的婴儿的胎儿肺成熟。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.
8
Survival without severe neonatal morbidity after antenatal betamethasone dose reduction: a post hoc analysis of a randomized non-inferiority trial.产前倍他米松剂量减少后无严重新生儿发病率的生存:一项随机非劣效性试验的事后分析。
Am J Obstet Gynecol. 2024 Oct;231(4):458.e1-458.e16. doi: 10.1016/j.ajog.2024.02.002. Epub 2024 Feb 9.
9
Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial.重复使用地塞米松或倍他米松治疗早产孕妇及其新生儿的发病率:ASTEROID 试验的二次分析。
PLoS One. 2022 Feb 22;17(2):e0263927. doi: 10.1371/journal.pone.0263927. eCollection 2022.
10
Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation.产前糖皮质激素治疗与妊娠32周前出生个体的长期代谢风险无关。
Arch Dis Child Fetal Neonatal Ed. 2008 Nov;93(6):F442-7. doi: 10.1136/adc.2007.128470. Epub 2008 May 1.

引用本文的文献

1
Prevalence and determinants of preterm birth among women of reproductive age in Kenya: a multilevel analysis of the 2022 Demographic Health Survey.肯尼亚育龄妇女早产的患病率及影响因素:2022年人口与健康调查的多层次分析
Ther Adv Reprod Health. 2025 Mar 20;19:26334941251327181. doi: 10.1177/26334941251327181. eCollection 2025 Jan-Dec.